Correlation Between Inhibrx and COSCIENS Biopharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and COSCIENS Biopharma, you can compare the effects of market volatilities on Inhibrx and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and COSCIENS Biopharma.
Diversification Opportunities for Inhibrx and COSCIENS Biopharma
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Inhibrx and COSCIENS is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Inhibrx i.e., Inhibrx and COSCIENS Biopharma go up and down completely randomly.
Pair Corralation between Inhibrx and COSCIENS Biopharma
Given the investment horizon of 90 days Inhibrx is expected to generate 0.77 times more return on investment than COSCIENS Biopharma. However, Inhibrx is 1.29 times less risky than COSCIENS Biopharma. It trades about -0.03 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.12 per unit of risk. If you would invest 1,580 in Inhibrx on September 2, 2024 and sell it today you would lose (54.00) from holding Inhibrx or give up 3.42% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. COSCIENS Biopharma
Performance |
| Timeline |
| Inhibrx |
| COSCIENS Biopharma |
Inhibrx and COSCIENS Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and COSCIENS Biopharma
The main advantage of trading using opposite Inhibrx and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| COSCIENS Biopharma vs. Tff Pharmaceuticals | COSCIENS Biopharma vs. Eliem Therapeutics | COSCIENS Biopharma vs. Inhibrx | COSCIENS Biopharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |